Request Sample Inquiry
Artificial Intelligence in Diagnostics Market

Artificial Intelligence In Diagnostics Market

Artificial Intelligence In Diagnostics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

142

Base Year:

2022

Date

Aug - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2253

Segments Covered
  • By Component By Component Software, Hardware, Services
  • By Therapeutic Area By Therapeutic Area Oncology, Neurodegenerative Disease, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Other Areas
  • By Application By Application Drug Optimization & Repurposing, Preclinical Testing, Other Applications
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.1 Billion
Revenue 2030Revenue 2030: USD 11.9 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 40.6%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. Global Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. Global Artificial Intelligence In Diagnostics Market - by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. Global Artificial Intelligence In Diagnostics Market - by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. Global Artificial Intelligence In Diagnostics Market - by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. Global Artificial Intelligence In Diagnostics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. North America Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. North America Artificial Intelligence In Diagnostics Market, by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. North America Artificial Intelligence In Diagnostics Market, by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. North America Artificial Intelligence In Diagnostics Market, by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. North America Artificial Intelligence In Diagnostics Market, by Country
      1. U.S.
        1. U.S. Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. U.S. Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. U.S. Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      2. Canada
        1. Canada Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Canada Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Canada Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      3. Mexico
        1. Mexico Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Mexico Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Mexico Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
  5. Europe Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. Europe Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. Europe Artificial Intelligence In Diagnostics Market, by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. Europe Artificial Intelligence In Diagnostics Market, by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. Europe Artificial Intelligence In Diagnostics Market, by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. Europe Artificial Intelligence In Diagnostics Market, by Country
      1. Germany
        1. Germany Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Germany Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Germany Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      2. UK
        1. UK Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. UK Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. UK Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      3. France
        1. France Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. France Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. France Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      4. Spain
        1. Spain Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Spain Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Spain Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      5. Italy
        1. Italy Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Italy Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Italy Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      6. BENELUX
        1. BENELUX Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. BENELUX Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. BENELUX Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      7. Rest of Europe
        1. Rest Of Europe Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Rest Of Europe Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Rest Of Europe Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
  6. Asia Pacific Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Artificial Intelligence In Diagnostics Market, by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. Asia Pacific Artificial Intelligence In Diagnostics Market, by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. Asia Pacific Artificial Intelligence In Diagnostics Market, by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. Asia Pacific Artificial Intelligence In Diagnostics Market, by Country
      1. China
        1. China Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. China Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. China Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      2. Japan
        1. Japan Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Japan Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Japan Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      3. India
        1. India Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. India Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. India Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      4. South Korea
        1. South Korea Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. South Korea Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. South Korea Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      5. South East Asia
        1. South East Asia Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. South East Asia Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. South East Asia Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
  7. Latin America Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. Latin America Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. Latin America Artificial Intelligence In Diagnostics Market, by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. Latin America Artificial Intelligence In Diagnostics Market, by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. Latin America Artificial Intelligence In Diagnostics Market, by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. Latin America Artificial Intelligence In Diagnostics Market, by Country
      1. Brazil
        1. Brazil Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Brazil Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Brazil Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      2. Argentina
        1. Argentina Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Argentina Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Argentina Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      3. Rest of Latin America
        1. Rest of Latin America Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Rest of Latin America Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Rest of Latin America Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
  8. Middle East & Africa Artificial Intelligence In Diagnostics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Artificial Intelligence In Diagnostics Market, by Component
      1. By Software
      2. By Hardware
      3. By Services
    4. Middle East & Africa Artificial Intelligence In Diagnostics Market, by Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Disease
      3. By Cardiovascular Disease
      4. By Metabolic Disease
      5. By Infectious Disease
      6. By Other Areas
    5. Middle East & Africa Artificial Intelligence In Diagnostics Market, by Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    6. Middle East & Africa Artificial Intelligence In Diagnostics Market, by Country
      1. GCC Countries
        1. GCC Countries Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. GCC Countries Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. GCC Countries Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      2. South Africa
        1. South Africa Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. South Africa Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. South Africa Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Component
          1. By Software
          2. By Hardware
          3. By Services
        2. Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Therapeutic Area
          1. By Oncology
          2. By Neurodegenerative Disease
          3. By Cardiovascular Disease
          4. By Metabolic Disease
          5. By Infectious Disease
          6. By Other Areas
        3. Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Application
          1. By Drug Optimization & Repurposing
          2. By Preclinical Testing
          3. By Other Applications
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Aidoc (U.S.)
    2. AliveCor Inc. (U.S.)
    3. Vuni Inc. (U.S.)
    4. Digital Diagnostics Inc. (U.S.)
    5. Siemens Healthineers (Germany)
    6. Neural Analytics (U.S.)
    7. Riverain Technologies (U.S.)
    8. Zebra Medical Vision Inc. (Israel)
    9. GE Healthcare (U.S.)
    10. Imagen Technologies (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Artificial Intelligence In Diagnostics valued at USD 1.1 Billion in 2022 and is expected to reach USD 11.9 Billion in 2030 growing at a CAGR of 40.6%.

  • The prominent players in the market are Aidoc (U.S.), AliveCor Inc. (U.S.), Vuni Inc. (U.S.), Digital Diagnostics Inc. (U.S.), Siemens Healthineers (Germany), Neural Analytics (U.S.), Riverain Technologies (U.S.), Zebra Medical Vision Inc. (Israel), GE Healthcare (U.S.), Imagen Technologies (U.S.).

  • The market is project to grow at a CAGR of 40.6% between 2023 and 2030.

  • The driving factors of the Artificial Intelligence In Diagnostics include

    • Growing Need to Incorporate AI into Medical Diagnosis

  • North America was the leading regional segment of the Artificial Intelligence In Diagnostics in 2022.